Proteomic analysis of prostate cancer metastasis-derived prostasomes

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 285-290

  Ronquist, K Göran ^a   Ronquist, Gunnar ^a   Larsson, Anders ^a   Carlsson, Lena ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Annexin; Exosomes; Metastasis; Prostasomes

Indexed keywords

ANGIOGENIC FACTOR; DIMETHYLARGININASE; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; LIPOCORTIN 1; LIPOCORTIN 5;

ARTICLE; CARCINOGENESIS; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; PRIORITY JOURNAL; PROSTASOME; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

BONE NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXOSOMES; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 77950544231     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Ronquist G and Brody I: The prostasome: its secretion and function in man. Biochim Biophys Acta 822: 203-218, 1985.
2. 2+-stimulated adenosine triphosphatase in human prostatic fluid: part I. Andrologia 10: 261-272, 1978.
3. 2+ and Ca 2+-stimulated adenosine triphosphatase in human prostatic fluid-part II. Andrologia 10: 427-433, 1978.
4. Johnstone RM, Adam M, Hammond JR, Orr L and Turbide C: Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262: 9412-9420, 1987.
5. Stoorvogel W, Kleijmeer MJ, Geuze HJ and Raposo G: The biogenesis and functions of exosomes. Traffic 3: 321-330, 2002.
6. Thery C, Zitvogel L and Amigorena S: Exosomes: composition, biogenesis and function. Nat Rev Immunol 2: 569-579, 2002.
7. Ronquist G, Nilsson BO and Hjerten S: Interaction between prostasomes and spermatozoa from human semen. Arch Androl 24: 147-157, 1990.
8. Carlini E, Palmerini CA, Cosmi EV and Arienti G: Fusion of sperm with prostasomes: effects on membrane fluidity. Arch Biochem Biophys 343: 6-12, 1997.
9. Minelli A, Allegrucci C, Mezzasoma I, Ronquist G, Lluis C and Franco R: CD26 and adenosine deaminase interaction: its role in the fusion between horse membrane vesicles and spermatozoa. Biol Reprod 61: 802-808, 1999.
10. Wang J, Lundqvist M, Carlsson L, Nilsson O, Lundkvist O and Ronquist G: Prostasome-like granules from the PC-3 prostate cancer cell line increase the motility of washed human spermatozoa and adhere to the sperm. Eur J Obstet Gynecol Reprod Biol 96: 88-97, 2001.
11. Carlsson L, Ronquist G, Eliasson R, Egberg N and Larsson A: Flow cytometric technique for determination of prostasomal quantity, size and expression of CD10, CD13, CD26 and CD59 in human seminal plasma. Int J Androl 29: 331-338, 2006.
12. Arienti G, Carlini E, Nicolucci A, Cosmi EV, Santi F and Palmerini CA: The motility of human spermatozoa as influenced by prostasomes at various pH levels. Biol Cell 91: 51-54, 1999.
13. Fabiani R, Johansson L, Lundkvist O and Ronquist G: Enhanced recruitment of motile spermatozoa by prostasome inclusion in swim-up medium. Hum Reprod 9: 1485-1489, 1994.
14. Breitbart H, Cohen G and Rubinstein S: Role of actin cytoskeleton in mammalian sperm capacitation and the acrosome reaction. Reproduction 129: 263-268, 2005.
15. Cross NL and Mahasreshti P: Prostasome fraction of human seminal plasma prevents sperm from becoming acrosomally responsive to the agonist progesterone. Arch Androl 39: 39-44, 1997.
16. Minelli A, Allegrucci C, Liguori L and Ronquist G: Ectodiadenosine polyphosphates hydrolase activity on human prostasomes. Prostate 51: 1-9, 2002.
17. Kelly RW, Holland P, Skibinski G, Harrison C, McMillan L, Hargreave T and James K: Extracellular organelles (prostasomes) are immunosuppressive components of human semen. Clin Exp Immunol 86: 550-556, 1991.
18. Skibinski G, Kelly RW, Harkiss D and James K: Immunosuppression by human seminal plasma-extracellular organelles (prostasomes) modulate activity of phagocytic cells. Am J Reprod Immunol 28: 97-103, 1992.
19. Babiker AA, Ronquist G, Nilsson UR and Nilsson B: Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis. Am J Reprod Immunol 47: 183-192, 2002.
20. Rooney IA, Atkinson JP, Krul ES, Schonfeld G, Polakoski K, Saffitz JE and Morgan BP: Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis. J Exp Med 177: 1409-1420, 1993.
21. Saez F, Motta C, Boucher D and Grizard G: Antioxidant capacity of prostasomes in human semen. Mol Hum Reprod 4: 667-672, 1998.
22. Saez F, Motta C, Boucher D and Grizard G: Prostasomes inhibit the NADPH oxidase activity of human neutrophils. Mol Hum Reprod 6: 883-891, 2000.
23. Carlsson L, Pahlson C, Bergquist M, Ronquist G and Stridsberg M: Antibacterial activity of human prostasomes. Prostate 44: 279-286, 2000.
24. Floryk D, Tollaksen SL, Giometti CS and Huberman E: Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5′-monophosphate dehydrogenase. Cancer Res 64: 9049-9056, 2004.
25. Nilsson BO, Egevad L, Jin M, Ronquist G and Busch C: Distribution of prostasomes in neoplastic epithelial prostate cells. Prostate 39: 36-40, 1999.
26. Sahlen G, Ahlander A, Frost A, Ronquist G, Norlen BJ and Nilsson BO: Prostasomes are secreted from poorly differentiated cells of prostate cancer metastases. Prostate 61: 291-297, 2004.
27. Ahmed K: Significance of the casein kinase system in cell growth and proliferation with emphasis on studies of the androgenic regulation of the prostate. Cell Mol Biol Res 40: 1-11, 1994.
28. Edelman AM, Blumenthal DK and Krebs EG: Protein serine/threonine kinases. Annu Rev Biochem 56: 567-613, 1987.
29. Wilson MJ: Protein kinases and protein phosphorylation in prostasomes. In: Prostasomes. Ronquist G and Nilsson BO (eds.). Stockholm, Portland Press Ltd, London, pp. 145-153, 2001.
30. Babiker AA, Ronquist G, Nilsson B and Ekdahl KN: Overexpression of ecto-protein kinases in prostasomes of metastatic cell origin. Prostate 66: 675-686, 2006.
31. Babiker AA, Nilsson B, Ronquist G, Carlsson L and Ekdahl KN: Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack. Prostate 62: 105-114, 2005.
32. Babiker AA, Hamad OA, Sanchez J, Ronquist G, Nilsson B and Ekdahl KN: Prothrombotic effect of prostasomes of metastatic cell and seminal origin. Prostate 67: 378-388, 2007.
33. Bellezza I, Aisa MC, Palazzo R, Costanzi E, Mearini E and Minelli A: Extracellular matrix degrading enzymes at the prostasome surface. Prostate Cancer Prostatic Dis 8: 344-348, 2005.
34. Carlsson L, Nilsson O, Larsson A, Stridsberg M, Sahlen G and Ronquist G: Characteristics of human prostasomes isolated from three different sources. Prostate 54: 322-330, 2003.
35. Ronquist KG, Carlsson L, Ronquist G, Nilsson S and Larsson A: Prostasome-derived proteins capable of eliciting an immune response in prostate cancer patients. Int J Cancer 119: 847-853, 2006.
36. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF and Thery C: Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12: 19-30, 2010.
37. Poliakov A, Spilman M, Dokland T, Amling CL and Mobley JA: Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 69: 159-167, 2009.
38. Johnstone RM: Revisiting the road to the discovery of exosomes. Blood Cells Mol Dis 34: 214-219, 2005.
39. Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE and Zhang HG: Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 176: 1375-1385, 2006.
40. Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W and Howell SB: Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 4: 1595-1604, 2005.
41. Crompton MR, Moss SE and Crumpton MJ: Diversity in the lipocortin/calpactin family. Cell 55: 1-3, 1988.
42. Gerke V and Moss SE: Annexins: from structure to function. Physiol Rev 82: 331-371, 2002.
43. Wallner BP, Mattaliano RJ, Hession C, Cate RL, Tizard R, Sinclair LK, Foeller C, Chow EP, Browing JL, Ramachandran KL and Pepinsky RB: Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 320: 77-81, 1986.
44. Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC and Cho S: Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun 337: 1283-1287, 2005.
45. Kollermann J, Schlomm T, Bang H, Schwall GP, von Eichel-Streiber C, Simon R, Schostak M, Huland H, Berg W, Sauter G, Klocker H and Schrattenholz A: Expression and prognostic relevance of annexin A3 in prostate cancer. Eur Urol 54: 1314-1323, 2008.
46. Larsson A, Ronquist G, Wulfing C, Eltze E, Bettendorf O, Carlsson L, Nilsson BO and Semjonow A: Antiprostasome antibodies: possible serum markers for prostate cancer metastasizing liability. Urol Oncol 24: 195-200, 2006.
47. Liu Y, Xiao Z, Li M, Li M, Zhang P, Li C, Li F, Chen Y, Yi H, Yao H and Chen ZC: Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 217: 54-64, 2008.
48. Lindahl M, Tagesson C and Ronquist G: Phospholipase A2 activity in prostasomes from human seminal plasma. Urol Int 42: 385-389, 1987.
49. Iwasaki A, Suda M, Nakao H, Nagoya T, Saino Y, Arai K, Mizoguchi T, Sato F, Yoshizaki H, Hirata M, Miyata T, Shidara Y, Murata M and Maki M: Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein. J Biochem 102: 1261-1273, 1987.
50. Pepinsky RB, Tizard R, Mattaliano RJ, Sinclair LK, Miller GT, Browning JL, Chow EP, Burne C, Huang KS and Pratt D: Five distinct calcium- and phospholipid-binding proteins share homology with lipocortin I. J Biol Chem 263: 10799-10811, 1988.
51. Andree HA, Stuart MC, Hermens WT, Reutelingsperger CP, Hemker HC, Frederik PM and Willems GM: Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 267: 17907-17912, 1992.
52. 2+ and phospholipid binding protein. J Biol Chem 263: 8037-8043, 1988.
53. Gerke V and Moss SE: Annexins and membrane dynamics. Biochim Biophys Acta 1357: 129-154, 1997.
54. Megli FM, Selvaggi M, Liemann S, Quagliariello E and Huber R: The calcium-dependent binding of annexin V to phospholipid vesicles influences the bilayer inner fluidity gradient. Biochemistry 37: 10540-10546, 1998.
55. Andersen MH, Berglund L, Petersen TE and Rasmussen JT: Annexin-V binds to the intracellular part of the beta(5) integrin receptor subunit. Biochem Biophys Res Commun 292: 550-557, 2002.
56. 2+- dependent apoptosis. Proc Natl Acad Sci USA 99: 8054-8059, 2002.
57. Wen Y, Edelman JL, Kang T and Sachs G: Lipocortin V may function as a signaling protein for vascular endothelial growth factor receptor-2/Flk-1. Biochem Biophys Res Commun 258: 713-721, 1999.
58. Rintala-Dempsey AC, Rezvanpour A and Shaw GS: S100-annexin complexes-structural insights. FEBS J 275: 4956-4966, 2008.
59. Knipp M, Charnock JM, Gamer CD and Vasak M: Structural and functional characterization of the Zn(II) site in dimethylargininase-1 (DDAH-1) from bovine brain. Zn(II) release activates DDAH-1. J Biol Chem 276: 40449-40456, 2001.
60. Chinje EC and Stratford IJ: Role of nitric oxide in growth of solid tumours: a balancing act. Essays Biochem 32: 61-72, 1997.
61. Fukumura D, Yuan F, Endo M and Jain RK: Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am J Pathol 150: 713-725, 1997.
62. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P and Ledda F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044, 1994.
63. Chin K, Kurashima Y, Ogura T, Tajiri H, Yoshida S and Esumi H: Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15: 437-442, 1997.
64. Kostourou V, Robinson SP, Cartwright JE and Whitley GS: Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis. Br J Cancer 87: 673-680, 2002.
65. Ronquist G and Nilsson BO: The Janus-faced nature of prostasomes: their pluripotency favours the normal reproductive process and malignant prostate growth. Prostate Cancer Prostatic Dis 7: 21-31, 2004.